Huizhong Xiong, S. Mittman, Ryan Rodriguez, M. Moskalenko, P. Sanchez, Yagai Yang, R. Cubas
{"title":"A120:反应性和非反应性同基因小鼠肿瘤模型的瘤内树突状细胞动力学","authors":"Huizhong Xiong, S. Mittman, Ryan Rodriguez, M. Moskalenko, P. Sanchez, Yagai Yang, R. Cubas","doi":"10.1158/2326-6074.CRICIMTEATIAACR18-A120","DOIUrl":null,"url":null,"abstract":"Conventional dendritic cells (cDC) play a vital role in T-cell-mediated antitumor immunity by transporting and cross-presenting tumor antigens to CD8 T-cells in draining lymph nodes (dLN) and tumor tissue. DC maturation and antigen uptake takes place in the tumor, which can be heavily affected by the suppressive tumor microenvironment. Intratumoral DCs are a scarce population and their phenotypes and functions have not been fully understood. Here we thoroughly characterized cDC phenotypes and dynamics in a variety of commonly used syngeneic murine tumor models, both at baseline and following anti-PD-L1 (aPDL1) treatment to investigate the correlation and potential contribution of DCs to response. Surprisingly, we observed a lower density of intratumoral DCs in responsive tumor models when compared to nonresponsive ones and their abundance was further reduced by aPDL1 treatment in an IFNg-dependent manner. Their PDL1 expression levels, albeit lower than tumor macrophages, were positively correlated with response. These results demonstrate an inverse correlation between intratumoral DCs and aPDL1-mediated antitumor immunity across different syngeneic murine tumor models, and ongoing studies are exploring the fates of these intratumoral DCs with a focus on their causal relation with the efficacy of immunotherapy. Citation Format: Huizhong Xiong, Stephanie Mittman, Ryan Rodriguez, Marina Moskalenko, Patricia Pacheco Sanchez, Yagai Yang, Rafael Cubas. Intratumoral dendritic cell dynamics in responsive and nonresponsive syngeneic murine tumor models [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr A120.","PeriodicalId":22141,"journal":{"name":"Tackling the Tumor Microenvironment: Beyond T-cells","volume":"28 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract A120: Intratumoral dendritic cell dynamics in responsive and nonresponsive syngeneic murine tumor models\",\"authors\":\"Huizhong Xiong, S. Mittman, Ryan Rodriguez, M. Moskalenko, P. Sanchez, Yagai Yang, R. Cubas\",\"doi\":\"10.1158/2326-6074.CRICIMTEATIAACR18-A120\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Conventional dendritic cells (cDC) play a vital role in T-cell-mediated antitumor immunity by transporting and cross-presenting tumor antigens to CD8 T-cells in draining lymph nodes (dLN) and tumor tissue. DC maturation and antigen uptake takes place in the tumor, which can be heavily affected by the suppressive tumor microenvironment. Intratumoral DCs are a scarce population and their phenotypes and functions have not been fully understood. Here we thoroughly characterized cDC phenotypes and dynamics in a variety of commonly used syngeneic murine tumor models, both at baseline and following anti-PD-L1 (aPDL1) treatment to investigate the correlation and potential contribution of DCs to response. Surprisingly, we observed a lower density of intratumoral DCs in responsive tumor models when compared to nonresponsive ones and their abundance was further reduced by aPDL1 treatment in an IFNg-dependent manner. Their PDL1 expression levels, albeit lower than tumor macrophages, were positively correlated with response. These results demonstrate an inverse correlation between intratumoral DCs and aPDL1-mediated antitumor immunity across different syngeneic murine tumor models, and ongoing studies are exploring the fates of these intratumoral DCs with a focus on their causal relation with the efficacy of immunotherapy. Citation Format: Huizhong Xiong, Stephanie Mittman, Ryan Rodriguez, Marina Moskalenko, Patricia Pacheco Sanchez, Yagai Yang, Rafael Cubas. Intratumoral dendritic cell dynamics in responsive and nonresponsive syngeneic murine tumor models [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr A120.\",\"PeriodicalId\":22141,\"journal\":{\"name\":\"Tackling the Tumor Microenvironment: Beyond T-cells\",\"volume\":\"28 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tackling the Tumor Microenvironment: Beyond T-cells\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A120\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tackling the Tumor Microenvironment: Beyond T-cells","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
传统树突状细胞(cDC)在t细胞介导的抗肿瘤免疫中发挥重要作用,通过将肿瘤抗原转运并交叉呈递到引流淋巴结(dLN)和肿瘤组织中的CD8 t细胞。DC成熟和抗原摄取发生在肿瘤中,这可能受到肿瘤微环境的严重影响。瘤内dc是一种罕见的种群,其表型和功能尚未完全了解。在这里,我们在各种常用的同基因小鼠肿瘤模型中,在基线和抗pd - l1 (aPDL1)治疗后,全面表征了cDC表型和动力学,以研究DCs与反应的相关性和潜在贡献。令人惊讶的是,与无反应的肿瘤模型相比,我们观察到应答性肿瘤模型中瘤内dc的密度较低,并且它们的丰度通过依赖ifng的方式通过aPDL1治疗进一步降低。它们的PDL1表达水平虽然低于肿瘤巨噬细胞,但与反应呈正相关。这些结果表明,在不同的同基因小鼠肿瘤模型中,肿瘤内dc与apdl1介导的抗肿瘤免疫之间存在负相关,并且正在进行的研究正在探索这些肿瘤内dc的命运,重点是它们与免疫治疗效果的因果关系。引文格式:熊慧忠,Stephanie Mittman, Ryan Rodriguez, Marina Moskalenko, Patricia Pacheco Sanchez, Yagai Yang, Rafael Cubas。反应性和非反应性同基因小鼠肿瘤模型的瘤内树突状细胞动力学[摘要]。第四届CRI-CIMT-EATI-AACR国际癌症免疫治疗会议:将科学转化为生存;2018年9月30日至10月3日;纽约,纽约。费城(PA): AACR;癌症免疫学杂志,2019;7(2增刊):摘要nr A120。
Abstract A120: Intratumoral dendritic cell dynamics in responsive and nonresponsive syngeneic murine tumor models
Conventional dendritic cells (cDC) play a vital role in T-cell-mediated antitumor immunity by transporting and cross-presenting tumor antigens to CD8 T-cells in draining lymph nodes (dLN) and tumor tissue. DC maturation and antigen uptake takes place in the tumor, which can be heavily affected by the suppressive tumor microenvironment. Intratumoral DCs are a scarce population and their phenotypes and functions have not been fully understood. Here we thoroughly characterized cDC phenotypes and dynamics in a variety of commonly used syngeneic murine tumor models, both at baseline and following anti-PD-L1 (aPDL1) treatment to investigate the correlation and potential contribution of DCs to response. Surprisingly, we observed a lower density of intratumoral DCs in responsive tumor models when compared to nonresponsive ones and their abundance was further reduced by aPDL1 treatment in an IFNg-dependent manner. Their PDL1 expression levels, albeit lower than tumor macrophages, were positively correlated with response. These results demonstrate an inverse correlation between intratumoral DCs and aPDL1-mediated antitumor immunity across different syngeneic murine tumor models, and ongoing studies are exploring the fates of these intratumoral DCs with a focus on their causal relation with the efficacy of immunotherapy. Citation Format: Huizhong Xiong, Stephanie Mittman, Ryan Rodriguez, Marina Moskalenko, Patricia Pacheco Sanchez, Yagai Yang, Rafael Cubas. Intratumoral dendritic cell dynamics in responsive and nonresponsive syngeneic murine tumor models [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr A120.